does select health cover tirzepatide SelectHealth (Mounjaro) Some US employers to drop

Semaglutide works by mimicking the effects of GLP-1, which tells the body that it is full and does not need more food

(1989) Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome

Medinos 2023 data show about 20% of users experience redness or swelling after injections, while roughly 30% report pain, and most of these complaints resolve with simple aftercare such as cooling compresses or short-term topical anti-itch

A retrospective cohort of 9,386 patients with lupus and type 2 diabetes found that GLP-1 receptor agonist exposure was associated with lower one-year relative risk of lupus nephritis, RR 0.59 with a 95% confidence interval of 0.40 to 0.86

its also about a more energised, confident version of yourself emerging through the process

Although a few studies have been conducted in humans, the results are mixed and ultimately the drug is not approved by the US Food and Drug Administration (FDA)